Catalent Appoints New Vice President Of Global Marketing And Strategy

Catalent Appoints New Vice President of Global Marketing and Strategy

Date: 05/10/2010

Somerset, NJ, May 10, 2010 — Catalent Pharma Solutions, Inc. announced the appointment of Elliott Berger to the position of Vice President of Global Marketing and Strategy. In this newly created role, Mr. Berger will be responsible for developing Catalent’s global marketing strategy, implementing marketing excellence across all business units as well as building Catalent’s brand equity.

Prior to joining Catalent, Mr. Berger’s most recent role was as the Vice President of Marketing in the Innovation Group at Johnson & Johnson Consumer Companies (J&J), a department responsible for the introduction of new-to-the-world product launches. Prior to this, he was Global Group Product Director for the Baby Business at J&J where he led digital strategy, marketing and media innovation for Johnson’s mega-brand. Earlier in his career, Mr. Berger was Global Director for J&J’s Baby Business leading the emerging markets growth strategy, resulting in significant double-digit growth across Russia, Middle East, India, China and Brazil.

Before joining J&J, Mr. Berger worked for Ernst & Young as a Managing Consultant in the Strategy and Transformation Practice. Prior to this, he ran his own business, focused on software distribution and DTC marketing.

Mr. Berger has a Bachelors degree in International Business from Hofstra University and a MBA in Management and Finance from the Leonard N. Stern School of Business at NYU.

“Elliott brings significant experience to Catalent, having worked in a range of senior marketing and strategy roles over the years, and I am excited to have him join the Catalent team,” said Will Downie, Group President, Sterile Technologies and Senior Vice President of Global Sales and Marketing for Catalent.

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit .

more products. better treatments. reliably supplied.™